The Individual and Societal Burden of Treatment-Resistant Depression: An Overview
- PMID: 37149341
- PMCID: PMC11008705
- DOI: 10.1016/j.psc.2023.02.001
The Individual and Societal Burden of Treatment-Resistant Depression: An Overview
Abstract
Major depressive disorder is characterized by depressed mood and/or anhedonia with neurovegetative symptoms and neurocognitive changes affecting an individual's functioning in multiple aspects of life. Treatment outcomes with commonly used antidepressants remain suboptimal. Treatment-resistant depression (TRD) should be considered after inadequate improvement with two or more antidepressant treatments of adequate dose and duration. TRD has been associated with increased disease burden including higher associated costs (both socially and financially) affecting both the individual and society. Additional research is needed to better understand the long-term burden of TRD to both the individual and society.
Keywords: Burden of depression; Depression; Major depressive disorder; Quality of life; Treatment-resistant depression.
Copyright © 2023 Elsevier Inc. All rights reserved.
Figures
References
-
- Malhi GS, Mann JJ. Depression. Lancet 2018;392(10161):2299–312. - PubMed
-
- Malhi GS, Das P, Mannie Z, et al. Treatment-resistant depression: problematic illness or a problem in our approach? Br J Psychiatry 2019;214(1):1–3. - PubMed
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. Arlington, VA: American Psychiatric Association Publishing; 2013.
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR. 5th edition, Text revision. ed. Arlington VA: American Psychiatric Association Publishing; 2022. p. 1050, lxix.
-
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163(11):1905–17. - PubMed
